EN DE
Watch Colony Bankcorp Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Colony Bankcorp Inc. (CBAN) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Colony Bankcorp Inc. stock $12.60, price $20.24, that is 37.8% below the price, quality 25 out of 100. Rating: strongly overvalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US

CB Colony Bankcorp Inc. logo Some data Nov 3, 2026

Colony Bankcorp Inc.

CBAN · US
Very expensive, weak quality

Our calculation puts a fair price 38% below what the stock costs today.

Highly profitable · 22.5% net margin (TTM)
2.3% dividend yield · Low payout
Upbeat coverage
Revenue last quarter +25% vs. a year ago.
Expensive Growth (revenue 5y +16.3 %/yr in USD)
Moderate moat 56/100
Insiders bought $211,945 (6M)
Some data
Fair value $12.60 · Strongly overvalued
Quality 25/100
Trails peers (3/14)
⚠ Dilution
Watch Colony Bankcorp Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$22.27 $7.94 Fair Value $12.60 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

60‑month range $7.94 – $22.27 · fair‑value band $11.11 – $13.92 · the $20.24 price screens above the $12.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow Colony Bankcorp in your weekly email

Every Wednesday you see whether Colony Bankcorp is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Colony Bankcorp, Inc. operates as the bank holding company for Colony Bank that provides various banking products and services to retail and commercial customers in the United States. It operates through Bank, Mortgage Banking, and Small Business Specialty Lending Division segments.

Show moreShow less

The company offers deposit products, including checking, savings, money market, and other deposit options; and treasury solutions, merchant services, and other financial tools that support businesses in managing cash flow and operational efficiency.

It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans and lines of credit; consumer loans; financing for marine and recreational vehicles; and small business administration and other government guaranteed loans.

In addition, the company offers wealth management, consumer insurance, internet banking services, electronic bill payment services, safe deposit box rentals, telephone banking, credit and debit card services, and remote depository products, as well as access to a network of ATMs. Further, it provides health savings accounts, student savings, retirement and educational accounts, and certificates of deposit; financial advisory services; lot and small acreage loans, auto loans, working capital loans, USDA loan programs, healthcare lending, and equipment loans, as well as boat, RV, and ATV loans; agriculture lending for equipment, livestock, farmland, and crop production; homeowners, fixed life, auto, boat, renters, condo, ATV, motorcycle, and business insurance; liquidity management; and digital banking, mobile deposit, e-statements, and e-alerts services.

Colony Bankcorp, Inc. was founded in 1975 and is headquartered in Fitzgerald, Georgia.

Stock analysis

Colony Bankcorp Inc. (CBAN) currently trades at $20.24, while our model-based Fair Value estimate is $12.60, 38% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $17.43 per share, and 0 of the 6 models we run sit above the $20.24 price.

Bear case: the Dividend Discount group reads lowest at $5.70, and 6 of the 6 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $11.11 (bear) to $13.92 (bull), the price of $20.24 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 25/100 (below-average quality), in the Financial Services sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Colony Bankcorp Inc. reported revenue of $186M in FY2025 versus $107M in FY2021, a compound +14.9%/yr. Reported net income was $28.3M in FY2025, compounding +10.9%/yr from FY2021.

Key figures

Market cap $429M Small · P/E ratio 12.3 · P/S ratio 2.95 · EPS (TTM) $1.65 · Dividend yield 2.3% · Net margin 22.5% · Return on equity 9.6% · Return on assets (EBIT) 0.9% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (medium confidence).

What moves the price

The share trades about 9% below its 52-week high and 28% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −28% fair-value upside, at −38%, CBAN screens richer than that median.

Fair Value models

Bear $11.11 Fair Value $12.60 Bull $13.92
Price $20.24 · Downside -37.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($1.01 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income $14.19 $14.82 $16.38 76
Gordon GGM $3.20 $6.15 $8.98 67
DDM Multi-Stage $3.20 $5.24 $6.52 67
All 6 models by family
Dividend Discount
Gordon GGM $3.20 $6.15 $8.98 67
DDM Multi-Stage $3.20 $5.24 $6.52 67
Multiples
P/E Multiple $12.98 $17.31 $21.63 63
P/B Multiple $13.15 $17.54 $21.92 55
Asset-Based
NCAV (Graham) $7.17 $9.60 $14.33 54
Economic Profit
Residual Income $14.19 $14.82 $16.38 76

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 25/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 26
How much profit the company makes from its sales and capital
Quality Growth 47
Are margins and returns getting better?
Cashflow 5
Do the profits arrive as real cash?
Financial strength 2
Debt, balance sheet and risk of trouble
Investment 57
Does it invest with discipline instead of growing at any price?
Low Volatility 90
How calm the share price moves, does not count
Price momentum 48
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 65
Distance to the 52-week high, does not count
New shares 7
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director bought shares worth $211,945, on Nov 5, 2026.

  • BuyEdward G CanupCHIEF BANKING OFFICER10× since Nov 17, 2025: 16,000 shares, avg. $20.36$325,815Nov 5, 2026
  • BuyDerek ShelnuttCFO250 shares at $19.50$4,875Mar 3, 2026

Plus 22 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+5.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.3%
Start year 2020 (pandemic). Over 10 years: +13.3% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.4%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+9.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.6%
Dividend (yield on the price)2.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.0% vs 4.8%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 19%
Pace: the 5-year rate starts in 2020 (pandemic)

CBAN screens overvalued: fair value 38% below the price. Compare with China Merchants Bank Co →

Earlier news

News mood ⓘNews mood, the average tone of recent news (97 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Colony Bankcorp Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Banks - Regional · 996 stocks

Beats the industry median on 3/14 measures
Overall it trails its industry peers.
Valuation
Quality Score 25 · Bottom 25%
Fair Value upside −37.8% · Bottom 25%
Profitability
Return on equity (12 months) 9.6% · Below median
Return on assets 0.8% · Below median
Net margin (12 months) 22.5% · Below median
Operating margin (12 months) 36.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) 25.3% · Top 25%
Dividend yield (12 months) 2.3% · Below median
Balance sheet
Debt / equity 0.69× · Above median

Valuation Multiplesvs Banks - Regional median · lower = cheaper

P/E (12 months) 12.3× · Pricier than median
P/B 1.14× · Cheaper than median
P/S (12 months) 2.95× · Cheaper than median
EV/EBITDA 18.8× · Priciest 25%
PEG 2.11× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 8
FUTURE (revenue growth)100 · sector 47
PAST (return on equity)38 · sector 43
HEALTH (low debt)–
DIVIDEND (yield)46 · sector 53

VALUE 0: the price sits above our fair-value range.

HEALTH: for banks, insurers and similar financial firms borrowed money is part of the business, so we do not rate debt here.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Banks - Regional stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Postal Savings Bank of China Co 601658 ¥5.53 ¥7.59 +37% vs CBAN
China Merchants Bank Co 600036 ¥42.88 ¥52.73 +23% vs CBAN
BNP Paribas SA BNP €91.93 €106.01 +15% vs CBAN
Intesa Sanpaolo S.p.A ISP €6.18 €4.49 −27% vs CBAN
State Bank of India SBIN ₹1,019 ₹736.65 −28% vs CBAN
UniCredit S.p.A UCG €76.80 €50.44 −34% vs CBAN
Mizuho Financial Group MFG $9.40 $5.89 −37% vs CBAN
DBS Group D05 69.72 SGD 40.39 SGD −42% vs CBAN
HDFC Bank Limited HDFCBANK ₹788.25 ₹406.39 −48% vs CBAN
ICICI Bank Limited ICICIBANK ₹1,571 ₹615.63 −61% vs CBAN

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Colony Bankcorp Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Colony Bankcorp Inc. Fair Value". https://www.fairvalue-calculator.com/stock/CBAN

Frequently asked questions

Is Colony Bankcorp Inc. (CBAN) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of $12.60 versus a price of $20.24, about 38% lower (overvalued).
What is the fair value of CBAN?
Our model-based fair value for Colony Bankcorp Inc. is $12.60 (as of Nov 3, 2026), built from audited fundamentals. The current price: $20.24.
What is the quality score of CBAN?
Colony Bankcorp Inc. has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Colony Bankcorp Inc. (CBAN)?
Our model-based price target is the fair value of $12.60 (as of Nov 3, 2026) from 6 valuation models. Cautious scenario $11.11, optimistic scenario $13.92. It is a calculation from audited fundamentals, not an analyst target.
What is the Colony Bankcorp Inc. stock forecast for 2026?
Our models put fair value at $12.60, about 38% lower versus a price of $20.24 (overvalued). Cautious scenario $11.11, optimistic scenario $13.92. The calculation is refreshed regularly with new filings.
What is the revenue of Colony Bankcorp Inc. (CBAN)?
Colony Bankcorp Inc. reported trailing-twelve-month revenue of about $145M (latest available figure, as of Nov 3, 2026).
Does Colony Bankcorp Inc. pay a dividend?
Colony Bankcorp Inc. currently shows a dividend yield of 2.32% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of Colony Bankcorp Inc. (CBAN) and when is the ex-dividend date?
Colony Bankcorp Inc. pays a dividend of $0.47 per share a year, a dividend yield of 2.3%. The last ex-dividend date was Aug 5, 2026. A dividend has been paid every year since 2017. The payout ratio is 28.5% of earnings. Our assessment: Low payout. A low payout ratio: the dividend takes at most 60 % of earnings. Whether free cash flow covers it as well, we cannot see for this company.
What is the intrinsic value of Colony Bankcorp Inc. (CBAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Colony Bankcorp Inc. it is $12.60 per share (as of Nov 3, 2026), against a price of $20.24. It is the blended result of 6 valuation models in 4 families (Dividend Discount, Multiples, Asset-Based, Economic Profit).
Is Colony Bankcorp Inc. stock overvalued or undervalued in 2026?
As of Nov 3, 2026, CBAN trades above its calculated fair value: price $20.24, fair value $12.60, a gap of about −38% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CBAN?
No. The price is what the market pays today ($20.24); the fair value is what the company's own numbers justify ($12.60). For Colony Bankcorp Inc. the two are $7.64 per share apart. That gap is exactly why we show both numbers side by side.
How much is Colony Bankcorp Inc. worth?
The market values Colony Bankcorp Inc. at about $429M (market capitalisation, as of Nov 3, 2026). Per share that is $20.24; our models calculate a fair value of $12.60 per share.
What do the bullish and bearish scenarios say about CBAN?
Our models span a range for Colony Bankcorp Inc.: cautious scenario $11.11, base $12.60, optimistic $13.92 per share (as of Nov 3, 2026, price $20.24). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CBAN?
Colony Bankcorp Inc. trades at a price-to-earnings ratio of 12.3 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $12.60 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2020, FY2025 ex one-offs: 11.5. Other multiples: PEG 2.1, P/B 1.1, P/S 2.9, EV/EBITDA 18.8.
What is the PEG ratio of CBAN?
The PEG ratio of Colony Bankcorp Inc. is 2.11 (P/E divided by earnings growth, as of Nov 3, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Colony Bankcorp Inc. (CBAN)?
Balance-sheet figures for Colony Bankcorp Inc. (as of Nov 3, 2026): return on equity 9.6%, debt of 0.69 per unit of equity. They feed the Quality Score of 25/100, which measures business quality independently of the share price.
How far is CBAN from its 52-week high?
Colony Bankcorp Inc. trades at $20.24, about 9% below its 52-week high of $22.27 and 28% above the low of $15.84 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $12.60 is for.
Which stocks are comparable to Colony Bankcorp Inc.?
From the same area (Financial Services) we also value China Merchants Bank Co, DBS Group, UniCredit S.p.A, Mizuho Financial Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Colony Bankcorp Inc. stock attractive at the current price?
The data as of Nov 3, 2026: price $20.24, calculated fair value $12.60 (−38%), Quality Score 25/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CBAN calculated?
We run Colony Bankcorp Inc. through 6 models from 4 families: Dividend Discount, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of $12.60 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Colony Bankcorp Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Colony Bankcorp Inc. (CBAN)?
The closing price on Nov 6, 2026 was $20.24. Our model-based fair value is $12.60, about 38% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Colony Bankcorp Inc. right now?
The price sits above even our optimistic bull case ($13.92). The favourable scenario is already priced in. Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Colony Bankcorp Inc. (CBAN) come from?
Earnings per share at Colony Bankcorp Inc. grew +4.2 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.0 %, EBIT margin −2.5 %, tax rate +1.7 %, residual (interest, one-offs) +0.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Colony Bankcorp Inc.

How large is the market capitalisation of Colony Bankcorp Inc. (CBAN)?
The market capitalisation of Colony Bankcorp Inc. is $429M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Colony Bankcorp Inc. (CBAN)?
The price-to-sales ratio of Colony Bankcorp Inc. is 2.95 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Colony Bankcorp Inc. (CBAN)?
Earnings per share at Colony Bankcorp Inc. are $1.65 (price ÷ EPS = P/E 12.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Colony Bankcorp Inc. (CBAN)?
The dividend yield of Colony Bankcorp Inc. is 2.3% (payout 28.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Colony Bankcorp Inc. (CBAN)?
The net margin of Colony Bankcorp Inc. is 22.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Colony Bankcorp Inc. (CBAN)?
The return on equity (ROE) of Colony Bankcorp Inc. is 9.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Colony Bankcorp Inc. (CBAN)?
On an EBIT basis the return on assets of Colony Bankcorp Inc. is 0.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Colony Bankcorp Inc. (CBAN)?
The operating margin of Colony Bankcorp Inc. is 36.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Colony Bankcorp Inc. (CBAN)?
Revenue at Colony Bankcorp Inc. is growing +25.3% versus a year earlier (3y avg +13.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Colony Bankcorp Inc. (CBAN)?
Earnings per share at Colony Bankcorp Inc. are growing +11.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Colony Bankcorp Inc. (CBAN) generate?
The free cash flow of Colony Bankcorp Inc. is −$6.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Colony Bankcorp Inc. (CBAN) carry?
The net debt of Colony Bankcorp Inc. is $231M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Colony Bankcorp Inc. in the live analysis

One click puts Colony Bankcorp Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.